Cargando…
Efficacy and safety evaluation of Fanhdi(®), a plasma‐derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study
Autores principales: | Jimenez‐Yuste, Victor, Núñez, Laura, Alvarez‐Roman, Maria Teresa, Martin‐Salces, Monica, Haya, Saturnino, Federici, Augusto B., Grifols, Carlota, Mairal, Esther, Torres, Mireia, Páez, Antonio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10015987/ https://www.ncbi.nlm.nih.gov/pubmed/34735040 http://dx.doi.org/10.1111/hae.14453 |
Ejemplares similares
-
Hemophilia and von Willebrand disease: Factor VIII and von Willebrand factor
por: Sharma, Prashant
Publicado: (2019) -
Clinical Efficacy and Safety of Fanhdi(®), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study
por: Jiménez-Yuste, Víctor, et al.
Publicado: (2022) -
Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia A
por: Castaman, Giancarlo, et al.
Publicado: (2016) -
Subcellular platelet factor VIII antigen and von Willebrand factor
Publicado: (1975) -
How to keep the factor VIII/von Willebrand factor complex in the circulation
por: Denis, Cécile V., et al.
Publicado: (2021)